L
Lunac Therapeutics
LUNAC Therapeutics | Anticoagulant Discovery
About Lunac Therapeutics
LUNAC Therapeutics is a pioneering drug discovery company focused on developing next-generation oral and intravenous anticoagulants. These innovative treatments aim to prevent and treat life-threatening thrombotic events, such as blood clots, without the bleeding risks associated with current anticoagulants. The company's core technology targets activated Factor XII (FXIIa), a clotting enzyme crucial for pathological clot formation but not essential for normal bleeding control. This unique approach offers a safer alternative for patients at risk of thrombosis.
LUNAC Therapeutics primarily serves the healthcare sector, including hospitals, clinics, and patients requiring anticoagulation therapy. The company operates in the global pharmaceutical market, leveraging international venture funding and expertise from leading blood coagulation experts.
The business model revolves around the research, development, and eventual commercialization of its proprietary anticoagulant therapies. Revenue generation is expected through the sale of these therapies, licensing agreements, and potential partnerships with larger pharmaceutical companies.
Source: Dealroom company dataNews
Open roles
Lunac Therapeutics in the Leeds ecosystem
The Lunac Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Epidarex Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lunac Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lunac Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

